HealthLynked Corp. (OTCQB: HLYK) will host a two-day global conference that explores promising anti-aging innovations, genomics and other medical breakthroughs that will impact patient care for years to come.

Open to the public, the second annual Future of Healthcare Summit will be held from 7-9 p.m. on Friday, March 18 and Saturday, March 19 at Arthrex One Conference Center, 1 Arthrex Way in Naples, Florida. The summit is intended to help patients take charge of their healthcare decisions, and features presentations and discussions by eight distinguished speakers across medical disciplines.

Two-day general admission tickets for the Future of Healthcare Summit start at $90; one-day tickets start at $50. Two-day reserved tables, which seat four, start at $540; one-day reserved tables start at $300. Food and drinks will be available.

For more information and to purchase tickets, please visit FutureOfHealthcareSummit.com.

SUMMIT ITINERARY
Friday, March 18
• Dr. Michael Dent (artificial intelligence in healthcare)
• Dr. Pam Hughes (women’s nutrition and menopause)
• Bob Gasparini (cancer diagnostics)
• Ryan Kellar (revolutionizing orthopedic surgery)

Saturday, March 19
• Ryan Smith (epigenetic aging)
• Dr. Jonathan Jay (prostate cancer)
• Dr. Randy Miller (stem cells and regenerative medicine)
• Dr. Eduardo Maristany (heavy metal and environmental detox)

“The Future of Healthcare Summit is an event like no other – a chance to hear from healthcare experts and researchers on the latest healthcare trends and technologies that are here today and will impact us all in the next 10 years,” said Dr. Michael Dent, CEO of HealthLynked. “The summit allows people a chance to learn from experts from around the world about the latest advances in healthcare technology and what the future may hold.”

HealthLynked, a global healthcare network focused on care management of its members and a provider of healthcare technologies that connects doctors, patients and medical data, created the Future of Healthcare Summit to bring patients together with global thought leaders specializing in diverse healthcare disciplines. Speakers and attendees will explore advances, trends and new technology in medicine, including genomics, artificial intelligence, cancer diagnostics, gene editing, anti-aging and implant devices.

HealthLynked offers a number of applications that improve healthcare for its patient members, including its HealthLynked Network, DocLynk Telemedicine platform, CareLynk patient scheduling service, Qwick check application, CostLynk cost estimator, COVID-19 Tracker and Oohvie, a menstrual tracking application.

About HealthLynked Corp.

HealthLynked Corp. provides a solution for both patient members and providers to improve healthcare through the efficient exchange of medical information. The HealthLynked Network is a cloud-based platform that allows members to connect with their healthcare providers and take more control of their healthcare. Members enter their medical information, including medications, allergies, past surgeries, and personal health records, in one convenient online and secure location, free of charge. Participating healthcare providers can connect with their current, past and future patients through the system. Benefits to in-network providers include the ability to utilize the HealthLynked patent-pending patient access hub “PAH” for patient analytics. Other benefits for preferred providers include HLYK marketing tools to connect with their active and inactive patients to improve patient retention, access more accurate and current patient information, provide more efficient online scheduling, and to fill last-minute cancelations using the Company’s “real-time appointment scheduling” all within its mobile application. Preferred providers pay a monthly fee to access these HealthLynked services. For additional information about HealthLynked Corporation, please visit www.healthlynked.com and connect with HealthLynked on Twitter, Facebook, Instagram, YouTube and LinkedIn.

Forward-Looking Statements

Forward-Looking Statements in this press release, which are not historical facts, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Our actual results, including as a result of any acquisitions, performance, or achievements may differ materially from those expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such as “may,” “could,” “expect,” “intend,” “plan,” “seek,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “continue,” “likely,” “will,” “would” and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Such forward-looking statements are necessarily based upon estimates and assumptions that, while considered reasonable by our management, and us are inherently uncertain. We caution you not to place undue reliance on any forward-looking statements, which are made as of the date of this press release. We undertake no obligation to update publicly any of these forward-looking statements to reflect actual results, new information or future events, changes in assumptions or changes in other factors affecting forward-looking statements, except to the extent required by applicable laws. If we update one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements. Certain risks and uncertainties applicable to our operations and us are described in the “Risk Factors” section of our most recent Annual Report on Form 10-K and in other filings we have made with the U.S. Securities and Exchange Commission. These reports are publicly available at www.sec.gov.